EcoDrugPlus

Prostaglandin I2 Receptor

Ensembl ID : ENSPLOG00000005755
Gene Symbol: PTGIR
4 Cross references
187 Possible Orthologues:

Prostaglandin-Endoperoxide Synthase 1

Ensembl ID : ENSPLOG00000017799
Gene Symbol: PTGS1
4 Cross references
256 Possible Orthologues:

Prostaglandin-Endoperoxide Synthase 2

Ensembl ID : ENSPLOG00000020105
Gene Symbol: PTGS2
4 Cross references
237 Possible Orthologues:

Proteasome 20s Subunit Alpha 1

Ensembl ID : ENSPLOG00000009654
Gene Symbol: PSMA1
4 Cross references
251 Possible Orthologues:

Proteasome 20s Subunit Alpha 2

Ensembl ID : ENSPLOG00000012010
Gene Symbol: PSMA2
4 Cross references
246 Possible Orthologues:

Proteasome 20s Subunit Alpha 3

Ensembl ID : ENSPLOG00000004568
Gene Symbol: PSMA3
4 Cross references
236 Possible Orthologues:

Proteasome 20s Subunit Alpha 4

Ensembl ID : ENSPLOG00000018120
Gene Symbol: PSMA4
4 Cross references
250 Possible Orthologues:

Proteasome 20s Subunit Alpha 5

Ensembl ID : ENSPLOG00000007587
Gene Symbol: PSMA5
4 Cross references
210 Possible Orthologues:

Proteasome 20s Subunit Alpha 6

Ensembl ID : ENSPLOG00000001875
Gene Symbol: PSMA6
4 Cross references
256 Possible Orthologues:

Proteasome 20s Subunit Alpha 7

Ensembl ID : ENSPLOG00000014943
Gene Symbol: PSMA7
4 Cross references
155 Possible Orthologues:

Proteasome 20s Subunit Alpha 8

Ensembl ID : ENSPLOG00000021774
Gene Symbol: PSMA8
4 Cross references
197 Possible Orthologues:

Proteasome 20s Subunit Beta 1

Ensembl ID : ENSPLOG00000005182
Gene Symbol: PSMB1
4 Cross references
215 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).